Paladin Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.45K Hold
20
– – ﹤0.01% 152
2026
Q2
$4.75K Hold
20
– – ﹤0.01% 160
2026
Q1
$4.23K Hold
20
– – ﹤0.01% 163
2025
Q4
$4.11K Buy
+20
New +$3.76K ﹤0.01% 164

Other funds holding CAH

Paladin Partners's CAH Position: Q3 2026 in Review

Paladin Partners held its Cardinal Health (CAH) position steady in Q3 2026 at 20 shares worth $4.45K. The position accounts for ﹤0.01% of the portfolio, ranked #152.

Paladin Partners first reported a position in CAH in Q4 2025 and has held it in 4 quarters since. The position peaked at $4.75K in Q2 2026. 58 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • Paladin Partners held 20 shares of Cardinal Health worth $4.45K as of Q3 2026.
  • Paladin Partners left its Cardinal Health share count unchanged in Q3 2026.
  • Cardinal Health made up ﹤0.01% of Paladin Partners's portfolio in Q3 2026, its #152 holding.
  • Paladin Partners first reported a position in Cardinal Health in Q4 2025 and has held it in 4 quarters since.
  • Paladin Partners's Cardinal Health position peaked at $4.75K in Q2 2026.
  • 58 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Paladin Partners's 13F filing for Q3 2026, filed 6 Oct 2026.